Search results
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 3 days agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP, Chief Regulatory & Quality ... By...
Investing.com· 6 days agoOn May 31, 2024, Ourania Tatsis, EVP, Chief Regulatory & Quality Officer of Vertex Pharmaceuticals...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 3 days agoMost readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4.1%...
Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
GuruFocus.com via Yahoo Finance· 5 days agoOn June 3, 2024, David Guyer, a Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a...
... Less Likely To Approve A Large Pay Rise For Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO For...
Simply Wall St. via Yahoo Finance· 2 days ago(NASDAQ:AUPH) has struggled to grow and now shareholders are sitting on a loss. What is concerning...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Director Bonnie L. Bassler Sells 827 Shares of Stock
ETF DAILY NEWS· 2 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Bonnie L. Bassler sold 827 shares of the firm’s stock in a transaction dated Wednesday ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by First National Bank of Omaha
ETF DAILY NEWS· 2 days agoFirst National Bank of Omaha reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.1% in the 4th quarter, according ...
Ori Gutwerg Sells 2,985 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock
ETF DAILY NEWS· 3 days agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) SVP Ori Gutwerg sold 2,985 shares of the stock in a transaction dated Wednesday, June 5th. The ...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 3 days agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating ...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 3 days agoPharmaceuticals' EPS declined by 9.8% over the past three years while total shareholder loss over...